Using a new technology and computational method, researchers have uncovered a biomarker capable of accurately predicting outcomes in meningioma brain tumors and breast cancers.

Duracell® batteries will be integrated into KIFFIK Biomonitoring Devices, such as health monitors, that detect various ...

Researchers at Fred Hutch and MD Anderson discovered RNA Polymerase II on histone genes as a biomarker for cancer ...

Schematic illustration of minimally invasive ISF extraction and glucose recovery using highly swellable spiral MNs with the ...

According to Future Market Insights’ updated report, the renal biomarker market is projected to experience steady growth over ...

Researchers at the University of Pittsburgh have devised a biomarker test that can spot small amounts of clumping tau protein ...

The new technology – Cleavage Under Targeted Accessible Chromatin (CUTAC) – focuses on small, fragmented DNA non-coding ...

The "Global Cardiac Biomarkers Diagnostics Industry, 2024-2029" report has been added to ResearchAndMarkets.com's offering. This research service provides an overview of the global cardiac biomarkers ...

BROOMFIELD, Colo. - Aclarion, Inc. (NASDAQ:ACON, ACONW), a healthcare technology company, announced today it has received a Notice of Allowance from the U.S. Patent and Trademark Office for a patent ...